MYO שווי כולל של נכסי החברה Myomo Inc.

The development of exoskeleton manufacturer Myomo, Inc. (MYO) relies on solo expansion and partnerships with rehabilitation centers, while the success of the model depends on insurance company payouts and documented patient progress. This chart illustrates the price action of total assets, which currently stand at 37.02, as shown below. Under the leadership of Paul Gudanis, the team focuses on technological leadership and expanding access to device payment options, helping individuals regain upper limb motor function.

The growth of total resources at Myomo, Inc. (MYO), combining equity and liabilities, is currently being bolstered by sales expansion driven by the broadening of Medicare government programs. The trend reflected in the company's total assets is calculated inversely via ROA, allowing investors to promptly identify structural shifts in assets and assess the efficiency of business scaling without the risk of overpaying for redundant resources.